Treatment of patients with KRAS wild type advanced colorectal cancer with 5-fluorouracil (5-FU) or 5-FU plus an epidermal growth factor receptor inhibitor (cetuximab) based on a comprehensive geriatric assessment
Wedding, U., Messina, C., Mauer, M., Pallis, A., Harrison, J., Wildiers, H., Peeters, M.Volume:
4
Language:
english
Journal:
Journal of Geriatric Oncology
DOI:
10.1016/j.jgo.2013.09.067
Date:
October, 2013
File:
PDF, 50 KB
english, 2013